Global Multimodal Imaging Market to Reach $3.1 Billion by 2027

ReportLinker

In the changed post COVID-19 business landscape, the global market for Multimodal Imaging estimated at US$2. 5 Billion in the year 2020, is projected to reach a revised size of US$3. 1 Billion by 2027, growing at a CAGR of 3.

New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Multimodal Imaging Industry" - https://www.reportlinker.com/p06032284/?utm_source=GNW
1% over the analysis period 2020-2027. PET / CT Systems, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$1.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the SPECT / CT Systems segment is readjusted to a revised 2.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $679.9 Million, While China is Forecast to Grow at 5.9% CAGR

The Multimodal Imaging market in the U.S. is estimated at US$679.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$629.9 Million by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$405.8 Million by the year 2027.



PET / MR Systems Segment to Record 3.7% CAGR

In the global PET / MR Systems segment, USA, Canada, Japan, China and Europe will drive the 3.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$338.4 Million in the year 2020 will reach a projected size of US$427.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 3.9% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -
Canon Medical Systems Corporation
Carl Zeiss AG
GE Healthcare
Heidelberg Engineering
Infraredx, Inc.
Koninklijke Philips N.V.
Mediso Medical Imaging Kft
MILabs B.V.
Neusoft Medical Systems Co., Ltd.
Northridge Tri-Modality Imaging, Inc.
PerkinElmer, Inc.
Shanghai United Imaging Healthcare Co., Ltd.
Siemens Healthineers
Spectrum Dynamics Medical
Topcon Corporation
United Imaging Healthcare Co., Ltd.


Read the full report: https://www.reportlinker.com/p06032284/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Multimodal Imaging - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Multimodal Imaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Multimodal Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Multimodal Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Cardiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Cardiology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Cardiology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Brain & Neurology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Brain & Neurology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Brain & Neurology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Ophthalmology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Ophthalmology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Ophthalmology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Diagnostic Imaging Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Diagnostic Imaging Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Diagnostic Imaging
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 28: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 31: World Multimodal Imaging Market Analysis of Annual
Sales in US$ Million for Years 2012 through 2027

Table 32: World Recent Past, Current & Future Analysis for PET/
CT Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 33: World Historic Review for PET / CT Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 34: World 15-Year Perspective for PET / CT Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 35: World Recent Past, Current & Future Analysis for
SPECT / CT Systems by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 36: World Historic Review for SPECT / CT Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 37: World 15-Year Perspective for SPECT / CT Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 38: World Recent Past, Current & Future Analysis for PET/
MR Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 39: World Historic Review for PET / MR Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 40: World 15-Year Perspective for PET / MR Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 41: World Recent Past, Current & Future Analysis for OCT/
Fundus Imaging Systems by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 42: World Historic Review for OCT / Fundus Imaging
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 43: World 15-Year Perspective for OCT / Fundus Imaging
Systems by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

III. MARKET ANALYSIS

UNITED STATES
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 44: USA Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 45: USA Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 46: USA 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 47: USA Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 48: USA Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 49: USA 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 50: USA Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 51: USA Historic Review for Multimodal Imaging by End-Use -
Hospitals, Diagnostic Imaging Centers and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 52: USA 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

CANADA
Table 53: Canada Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 54: Canada Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 55: Canada 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 56: Canada Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 57: Canada Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 58: Canada 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 59: Canada Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 60: Canada Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 61: Canada 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

JAPAN
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 62: Japan Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 63: Japan Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 64: Japan 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 65: Japan Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 66: Japan Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 67: Japan 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 68: Japan Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 69: Japan Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 70: Japan 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

CHINA
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 71: China Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 72: China Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 73: China 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 74: China Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 75: China Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 76: China 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 77: China Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: China Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 79: China 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

EUROPE
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 80: Europe Recent Past, Current & Future Analysis for
Multimodal Imaging by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 81: Europe Historic Review for Multimodal Imaging by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 82: Europe 15-Year Perspective for Multimodal Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 83: Europe Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: Europe Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 85: Europe 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 86: Europe Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 87: Europe Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 88: Europe 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 89: Europe Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 90: Europe Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 91: Europe 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

FRANCE
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 92: France Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 93: France Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 94: France 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 95: France Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 96: France Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 97: France 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 98: France Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 99: France Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 100: France 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

GERMANY
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 101: Germany Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 102: Germany Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 103: Germany 15-Year Perspective for Multimodal Imaging
by Technology - Percentage Breakdown of Value Sales for PET /
CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 104: Germany Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 105: Germany Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 106: Germany 15-Year Perspective for Multimodal Imaging
by Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 107: Germany Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 108: Germany Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 109: Germany 15-Year Perspective for Multimodal Imaging
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

ITALY
Table 110: Italy Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 111: Italy Historic Review for Multimodal Imaging by
Technology - PET / CT Systems, SPECT / CT Systems, PET / MR
Systems, OCT / Fundus Imaging Systems and Other Technologies
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 112: Italy 15-Year Perspective for Multimodal Imaging by
Technology - Percentage Breakdown of Value Sales for PET / CT
Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus
Imaging Systems and Other Technologies for the Years 2012, 2021 &
2027

Table 113: Italy Recent Past, Current & Future Analysis for
Multimodal Imaging by Application - Other Applications,
Oncology, Cardiology, Brain & Neurology and Ophthalmology -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 114: Italy Historic Review for Multimodal Imaging by
Application - Other Applications, Oncology, Cardiology, Brain &
Neurology and Ophthalmology Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 115: Italy 15-Year Perspective for Multimodal Imaging by
Application - Percentage Breakdown of Value Sales for Other
Applications, Oncology, Cardiology, Brain & Neurology and
Ophthalmology for the Years 2012, 2021 & 2027

Table 116: Italy Recent Past, Current & Future Analysis for
Multimodal Imaging by End-Use - Hospitals, Diagnostic Imaging
Centers and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 117: Italy Historic Review for Multimodal Imaging by
End-Use - Hospitals, Diagnostic Imaging Centers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 118: Italy 15-Year Perspective for Multimodal Imaging by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Imaging Centers and Other End-Uses for the Years
2012, 2021 & 2027

UNITED KINGDOM
Multimodal Imaging Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 119: UK Recent Past, Current & Future Analysis for
Multimodal Imaging by Technology - PET / CT Systems, SPECT / CT
Systems, PET / MR Systems, OCT / Fundus Imaging Systems and
Other Technologies - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032284/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001